Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas

Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas

<p>Supplemental figure correlating biological variance ratio (BVR) to contrast-to-variance ratio (CVR).</p>

Saved in:
Bibliographic Details
Main Author: Kimberley S. Samkoe (20877828) (author)
Other Authors: Hira Shahzad Sardar (21233329) (author), Jason R. Gunn (21233332) (author), Jonathan Thomas Elliott (21233335) (author), Sally Mansur (21233338) (author), Joachim Feldwisch (21233341) (author), Brian W. Pogue (17534777) (author), Konstantinos Linos (21233344) (author), Keith D. Paulsen (17534780) (author), Eric R. Henderson (21233347) (author)
Published: 2025
Subjects:
Cancer
Cancer Detection and Diagnosis
Therapeutic Research and Development
Clinical Research and Trials
Methods and Technology
Biological Agents & Therapies
Antireceptors
Clinical Imaging
Clinical Trial Results
Engineering
Imaging
Imaging probes
Sarcomas
Soft-tissue sarcoma
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<p>Supplemental figure correlating biological variance ratio (BVR) to contrast-to-variance ratio (CVR).</p>

Similar Items